The anesthetic method has the potential to allow physicians to keep injuries from evolving into neuropathic pain, a chronic form of pain that arises from flawed signals transmitted to damaged nerves.
The team combined saxitoxin, a powerful local anesthetic, with dexamethasone to prolong saxitoxin’s effects. The two ingredients contain liposomes for nontoxic delivery to the site of nerve or tissue damage.
More Articles on Anesthesia:
Teleflex Receives Initial Clearance for Rusch EZ-Blocker
FDA: Discontinue Use of New England Compounding Center Products to Avoid Meningitis Contamination
Study: Lighter Anesthesia Does Not Improve Mortality Rates for Certain Patients
